Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.1K
6.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mn-MIL-100-Derived CuO/Mn<sub>2</sub>O<sub>3</sub>-Mn<sub>5</sub>O<sub>8</sub> Composite Catalysts for Benzene Oxidation: Synergistic Effect and High Performance.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Integrating haplotype-enhanced HIV surveillance with national databases improves the resolution of transmission networks, drug resistance, and risk assessment.

Emerging microbes & infections·2026
Same author

Albumin-corrected anion gap and 28-/90-day mortality in cirrhotic patients with invasive fungal infection: a retrospective cohort study.

BMC infectious diseases·2026
Same author

Evaluation of large language models for PI-RADS score extraction from free-text prostate MRI reports: a comparative study with human readers.

Frontiers in oncology·2026
Same author

Evaluation of a HIV-1 drug resistance genotyping method based on high-throughput sequencing (HTS).

BMC infectious diseases·2026
Same author

Serum inflammatory markers and total antioxidant capacity in relation to sleep outcome in the elderly.

BMC geriatrics·2026

Related Experiment Video

Updated: May 4, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K

Identifying potential cancer driver genes by genomic data integration.

Yong Chen1, Jingjing Hao2, Wei Jiang2

  • 11] National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China [2] MOE Key Laboratory of Bioinformatics and Bioinformatics Division, TNLIST/Department of Automation, Tsinghua University, Beijing 100084, China.

Scientific Reports
|December 19, 2013
PubMed
Summary

MAXDRIVER, a new computational method, identifies potential cancer driver genes using copy number aberration data. It integrates genomic, disease, and phenotypic networks to uncover genes crucial for oncogenesis across multiple cancer types.

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.0K

Related Experiment Videos

Last Updated: May 4, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.6K
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.0K

Area of Science:

  • Genomics
  • Computational Biology
  • Cancer Research

Background:

  • Cancer is fundamentally a genomic disease driven by gene mutations leading to uncontrolled cellular functions.
  • Distinguishing driver genes (oncogenesis-causal) from passenger genes (irrelevant) is crucial for understanding cancer development.
  • Integrating large-scale genomic datasets is essential for identifying driver genes from cancer genome aberration regions.

Purpose of the Study:

  • To propose a computational method, MAXDRIVER, for identifying potential driver genes from cancer copy number aberration (CNA) regions.
  • To integrate diverse human genomic data for enhanced driver gene identification.
  • To investigate mechanisms of cancer development through genomic data analysis.

Main Methods:

  • Developed MAXDRIVER, a computational approach utilizing copy number aberration (CNA) data.
  • Integrated publicly available human genomic data, including fused gene functional similarity, gene-disease associations, and disease phenotypic similarity networks.
  • Employed optimization strategies to construct a heterogeneous network for driver gene prediction.

Main Results:

  • MAXDRIVER effectively recalled known associations between genes and cancers.
  • The method identified both previously known and novel driver genes in breast cancer, melanoma, and liver carcinoma.
  • Comparative analysis revealed three common predicted driver genes (CDKN2A, AKT1, RNF139) across these three cancer types.

Conclusions:

  • MAXDRIVER is a validated computational tool for identifying potential driver genes from genomic aberration data.
  • The method facilitates the discovery of key genes implicated in oncogenesis across various cancers.
  • Identification of common driver genes across different cancer types offers insights into shared mechanisms of cancer development.